News | August 16, 2023
Exor to buy 15% shareholding in Philips
Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases
Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Newcastle University’s Dr Srikanth Ramaswamy has been announced as one of six new Fellows selected for the 2023 Lister prize
This is the 166th ANDA out of Eugia Pharma Speciality Group facilities
Continuous learning is not just an option but a responsibility that every healthcare professional must shoulder
LyondellBasell is among the top three global polyolefin manufacturers in terms of capacity and sustainable solutions
Boostimmune will have access to WuXi XDC's fully integrated one-stop bioconjugate platform
India is committed to eliminating Lymphatic Filariasis by 2027, three years ahead of the global target through mission mode, multi partner, multi sector targeted drive
AushadhAI is purposefully designed to deliver significant advantages to the pharmaceutical supply chain's key constituents
The first such initiative under the MoU will involve establishing a Centre of Excellence for Renal Sciences at the Tomo Riba Institute of Health & Medical Sciences (TRIHMS)
Subscribe To Our Newsletter & Stay Updated
